Remi Gaston-Dreyfus - 29 Mar 2021 Form 4 Insider Report for Bionik Laboratories Corp.

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Issuer symbol
BNKL on OTC
Transactions as of
29 Mar 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 15:31:32 UTC
Previous filing
13 Dec 2021
Next filing
13 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Award +61,256 +4.3% 1,479,450 29 Mar 2021 Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA F1
holding BNKL Common Stock, par value $0.001 per share 61,256 29 Mar 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For director fees.